These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25328894)

  • 21. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system.
    Lastra G; Sowers JR
    Horm Mol Biol Clin Investig; 2013 Sep; 15(2):49-57. PubMed ID: 25436732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immune-metabolic regulatory roles of epoxyeicosatrienoic acids on macrophages phenotypic plasticity in obesity-related insulin resistance.
    Dai M; Wu L; Tu L; Xu X; Wang DW
    Prostaglandins Other Lipid Mediat; 2018 Nov; 139():36-40. PubMed ID: 30296488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue.
    Harford KA; Reynolds CM; McGillicuddy FC; Roche HM
    Proc Nutr Soc; 2011 Nov; 70(4):408-17. PubMed ID: 21835098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic approaches to target inflammation in type 2 diabetes.
    Goldfine AB; Fonseca V; Shoelson SE
    Clin Chem; 2011 Feb; 57(2):162-7. PubMed ID: 21098138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adipose Tissue Dendritic Cells: Critical Regulators of Obesity-Induced Inflammation and Insulin Resistance.
    Soedono S; Cho KW
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The accelerator hypothesis: insulin resistance as the central cause of type 1 and type 2 diabetes.
    Booker C
    Int J Obes (Lond); 2010 Jan; 34(1):210-1; author reply 212. PubMed ID: 19844208
    [No Abstract]   [Full Text] [Related]  

  • 27. An update on immune dysregulation in obesity-related insulin resistance.
    Daryabor G; Kabelitz D; Kalantar K
    Scand J Immunol; 2019 Apr; 89(4):e12747. PubMed ID: 30593678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance.
    Finucane OM; Reynolds CM; McGillicuddy FC; Roche HM
    Proc Nutr Soc; 2012 Nov; 71(4):622-33. PubMed ID: 22914223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action.
    Varma V; Yao-Borengasser A; Rasouli N; Nolen GT; Phanavanh B; Starks T; Gurley C; Simpson P; McGehee RE; Kern PA; Peterson CA
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1300-10. PubMed ID: 19336660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation, cytokines and insulin resistance: a clinical perspective.
    Wieser V; Moschen AR; Tilg H
    Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):119-25. PubMed ID: 23307037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties and functions of adipose tissue macrophages in obesity.
    Russo L; Lumeng CN
    Immunology; 2018 Dec; 155(4):407-417. PubMed ID: 30229891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virus-Induced Interferon-γ Causes Insulin Resistance in Skeletal Muscle and Derails Glycemic Control in Obesity.
    Šestan M; Marinović S; Kavazović I; Cekinović Đ; Wueest S; Turk Wensveen T; Brizić I; Jonjić S; Konrad D; Wensveen FM; Polić B
    Immunity; 2018 Jul; 49(1):164-177.e6. PubMed ID: 29958802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptive immunity in obesity and insulin resistance.
    Sell H; Habich C; Eckel J
    Nat Rev Endocrinol; 2012 Dec; 8(12):709-16. PubMed ID: 22847239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell- and tissue-specific epigenetic changes associated with chronic inflammation in insulin resistance and type 2 diabetes mellitus.
    Naidoo V; Naidoo M; Ghai M
    Scand J Immunol; 2018 Dec; 88(6):e12723. PubMed ID: 30589455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunometabolism of AMPK in insulin resistance and atherosclerosis.
    Fullerton MD; Steinberg GR; Schertzer JD
    Mol Cell Endocrinol; 2013 Feb; 366(2):224-34. PubMed ID: 22361321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabesity: an inflammatory metabolic condition.
    Schmidt MI; Duncan BB
    Clin Chem Lab Med; 2003 Sep; 41(9):1120-30. PubMed ID: 14598860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance.
    Lee BC; Lee J
    Biochim Biophys Acta; 2014 Mar; 1842(3):446-62. PubMed ID: 23707515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity heats up adipose tissue lymphocytes.
    O'Rourke RW; Lumeng CN
    Gastroenterology; 2013 Aug; 145(2):282-5. PubMed ID: 23806542
    [No Abstract]   [Full Text] [Related]  

  • 39. Ltb4r1 inhibitor: A pivotal insulin sensitizer?
    Esmaili S; George J
    Trends Endocrinol Metab; 2015 May; 26(5):221-2. PubMed ID: 25858788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune cell crosstalk in obesity: a key role for costimulation?
    Seijkens T; Kusters P; Chatzigeorgiou A; Chavakis T; Lutgens E
    Diabetes; 2014 Dec; 63(12):3982-91. PubMed ID: 25414012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.